CPT code 32562 denotes the daily, post-initial administration of an intrapleural fibrinolytic agent delivered via a chest tube or catheter to dissolve fibrinous material in the pleural space. The code captures ongoing therapeutic management of complex pleural collections such as loculated pleural effusions or empyema where fibrinous septations impair drainage. Nationally, this procedure influences hospital length of stay, resource utilization for chest tube management, and clinical pathways for pleural infection and complicated effusions.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what CPT code 32562 represents, the typical clinical and care settings where it is used, and the payment and coding context relevant to hospital-based and procedural care. The publication outlines benchmarks and policy considerations affecting coverage and reimbursement, clarifies clinical context for use of intrapleural fibrinolytics, and highlights practical coding guidance such as service-day reporting (this code applies on each treatment day after the first). Data elements not provided in the input are noted as unavailable. The material is intended for clinicians, coding professionals, and policy analysts seeking a national perspective on coding and operational implications for intrapleural fibrinolytic therapy.